TABITHA TILLEY: Open Payments
NPI 1902512007 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$552 in 8 payments from 4 companies in 2025. Trend: 2023 $244 · 2024 $234 · 2025 $552
Food & beverage: $552
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 3 | $168 |
| Supernus Pharmaceuticals, Inc. | 3 | $153 |
| Otsuka America Pharmaceutical, Inc. | 1 | $122 |
| Tris Pharma Inc | 1 | $110 |
Products named: ARISTADA, Qelbree, ABILIFY ASIMTUFII, Dyanavel XR.
Industry payments across AL — which companies pay providers there.
